Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 2 results out of 2
Data Insights
LY-4052031 by Eli Lilly and Co for Head And Neck Squamous Cell Carcinoma (HNSC): Likelihood of Approval
LY-4052031 is under clinical development by Eli Lilly and Co and currently in Phase I for Head And Neck Squamous...
Data Insights
LY-4052031 by Eli Lilly and Co for Ovarian Cancer: Likelihood of Approval
LY-4052031 is under clinical development by Eli Lilly and Co and currently in Phase I for Ovarian Cancer. According to...